| Literature DB >> 17686555 |
Verena Schlaphoff1, Christoph S Klade, Bernd Jilma, Sandra B Jelovcan, Markus Cornberg, Erich Tauber, Michael P Manns, Heiner Wedemeyer.
Abstract
Only very limited information on phenotype and function of vaccine-induced CD8+ T cells is available for humans. We investigated hepatitis C virus-specific CD8+ T cells after vaccination with the HCV peptide-vaccine IC41 which includes 5 MHC-class I and 3 MHC class-II-restricted epitopes. In healthy subjects, IC41 induced both HCV-specific central memory as well as effector CD8+ T cells which rapidly expanded upon antigen exposure in vitro. IFNgamma production was dependent on formulation of the synthetic peptides with the adjuvant poly-l-arginine. In chronic HCV patients, the frequency of HCV-specific CD8+ T cells increased after vaccination with a decline of CD45RA-positive effector memory cells in some but not all patients. Thus, this study suggests that HCV-specific memory cells can be induced by peptide vaccination and that a reversion of functional impaired phenotypes by therapeutic vaccination is possible in chronic HCV infection.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17686555 DOI: 10.1016/j.vaccine.2007.06.026
Source DB: PubMed Journal: Vaccine ISSN: 0264-410X Impact factor: 3.641